Bonesupport Holding Valuation
| BONEX Stock | SEK 249.00 4.00 1.63% |
At this time, the firm appears to be undervalued. Bonesupport Holding shows a prevailing Real Value of kr286.92 per share. The current price of the firm is kr249.0. Our model approximates the value of Bonesupport Holding from analyzing the firm fundamentals such as Return On Equity of -0.25, current valuation of 5.29 B, and Profit Margin of (0.25) % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Bonesupport Holding's price fluctuation is very steady at this time. Calculation of the real value of Bonesupport Holding is based on 3 months time horizon. Increasing Bonesupport Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bonesupport stock is determined by what a typical buyer is willing to pay for full or partial control of Bonesupport Holding AB. Since Bonesupport Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bonesupport Stock. However, Bonesupport Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 249.0 | Real 286.92 | Hype 249.0 | Naive 236.91 |
The intrinsic value of Bonesupport Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bonesupport Holding's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bonesupport Holding AB helps investors to forecast how Bonesupport stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bonesupport Holding more accurately as focusing exclusively on Bonesupport Holding's fundamentals will not take into account other important factors: Bonesupport Holding Total Value Analysis
Bonesupport Holding AB is currently anticipated to have takeover price of 5.29 B with market capitalization of 5.87 B, debt of 16.15 M, and cash on hands of 206.46 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bonesupport Holding fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
| 5.29 B | 5.87 B | 16.15 M | 206.46 M |
Bonesupport Holding Investor Information
About 13.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.27. Bonesupport Holding had not issued any dividends in recent years. Bonesupport Holding AB , an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids Sweden and internationally. The company was founded in 1999 and is headquartered in Lund, Sweden. BONESUPPORT HOLDING operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 78 people. For more info on Bonesupport Holding AB please contact the company at 46 4 62 86 53 70 or go to https://www.bonesupport.com.Bonesupport Holding Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bonesupport Holding has an asset utilization ratio of 61.9 percent. This implies that the Company is making kr0.62 for each dollar of assets. An increasing asset utilization means that Bonesupport Holding AB is more efficient with each dollar of assets it utilizes for everyday operations.Bonesupport Holding Ownership Allocation
Bonesupport Holding holds a total of 64.55 Million outstanding shares. Over half of Bonesupport Holding's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Bonesupport Holding. Please watch out for any change in the institutional holdings of Bonesupport Holding as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bonesupport Holding Profitability Analysis
The company reported the revenue of 212.88 M. Net Loss for the year was (80.67 M) with profit before overhead, payroll, taxes, and interest of 189.7 M.About Bonesupport Holding Valuation
The stock valuation mechanism determines the current worth of Bonesupport Holding AB on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Bonesupport Holding AB. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bonesupport Holding based exclusively on its fundamental and basic technical indicators. By analyzing Bonesupport Holding's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bonesupport Holding's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bonesupport Holding. We calculate exposure to Bonesupport Holding's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bonesupport Holding's related companies.Bonesupport Holding AB , an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids Sweden and internationally. The company was founded in 1999 and is headquartered in Lund, Sweden. BONESUPPORT HOLDING operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 78 people.
8 Steps to conduct Bonesupport Holding's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bonesupport Holding's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bonesupport Holding's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bonesupport Holding's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bonesupport Holding's revenue streams: Identify Bonesupport Holding's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bonesupport Holding's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bonesupport Holding's growth potential: Evaluate Bonesupport Holding's management, business model, and growth potential.
- Determine Bonesupport Holding's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bonesupport Holding's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Bonesupport Stock Analysis
When running Bonesupport Holding's price analysis, check to measure Bonesupport Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonesupport Holding is operating at the current time. Most of Bonesupport Holding's value examination focuses on studying past and present price action to predict the probability of Bonesupport Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonesupport Holding's price. Additionally, you may evaluate how the addition of Bonesupport Holding to your portfolios can decrease your overall portfolio volatility.